Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine versus fentanyl on pain and hemodynamic status in cataract surgery
IRCT20231231060584N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and fentanyl in cataract (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Pain severity and Hemodynamic status. Started Jan 2024; status: completed.
02
Drugs
dexmedetomidinefentanyl
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20231231060584N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231231060584N1.